Recap: Heron Therapeutics Q1 Earnings

Heron Therapeutics HRTX reported its Q1 earnings results on Thursday, May 11, 2023 at 04:01 PM.

Here's what investors need to know about the announcement.

Earnings

Heron Therapeutics missed estimated earnings by 35.0%, reporting an EPS of $-0.27 versus an estimate of $-0.2.

Revenue was up $6.16 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.11 which was followed by a 7.75% drop in the share price the next day.

To track all earnings releases for Heron Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.